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Auto anti-N is infrequently encountered and, in most reported
cases, does not cause clinical hemolysis. This case reports an auto
anti-N associated with severe hemolytic anemia (Hb = 2.7 g/dL) in
a 6-year-old Caucasian girl with a history of vomiting, fever, and
abdominal pain. Upon admission, she was found to have a
metabolic acidosis, secondary to her severe anemia, with abnormal
liver function tests. As in three other case reports, the autoimmune
hemolytic anemia resolved, with disappearance of the auto anti-N,
after corticosteroid therapy. Immunohematology 2005,21:63–65.
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Autoimmune hemolytic anemia can be caused by a
variety of underlying illnesses. We report a case of an
auto anti-N that caused a severe hemolytic anemia.
Case Report
A 6-year-old Caucasian girl (28.9 kg) with a 2-day
history of vomiting, fever, and abdominal pain
presented to her local physician and was found to be
jaundiced. That evening, her emesis worsened and her
urine was noted to be red. She presented to a local
hospital with an initial Hct of 8% and abnormal liver
function tests. She was transferred to our hospital; her
admission laboratory values were: Hb = 2.7 g/dL, Hct =
7.4%, WBC = 22.5 × 109/L, LDH = 7856 U/L (normal
470–900), AST = 587 U/L (normal 14–38), ALT = 434
U/L (normal 15–48), alkaline phosphatase = 232 U/L
(normal 150–380), gamma glutamyl transferase (GGT)
= 63 (normal 11–48), and total bilirubin = 12.3 mg/dL
(Fig. 1). Peripheral smear showed lymphocytosis, with
atypical lymphocytes, promyelocytes, myelocytes, and
plasmacytoid lymphocytes; polychromasia; and varying
shapes and sizes of RBCs with rouleaux. Anti-nuclear
antibody (ANA) was positive (speckled pattern, 1:80).
Tests for double-stranded DNA, Smith antigen (sm),
ribonucleoprotein (RNP), Sjogren’s syndrome A (SSA),
and Sjogren’s syndrome B (SSB) were all negative. The
test for infectious mononucleosis was negative. EBV
serologies were positive for IgG, but negative for IgM,
suggestive of a previous, nonrecent infection. In
addition, blood cultures were negative. At time of
transfer, the patient was in severe metabolic acidosis,
secondary to her severe anemia, with a pH of 7.17,
pCO2 of 23 mm Hg, pO2 of 47 mm Hg, and bicarbonate
(HCO3) of 9.3 mmol/L.
Two units of group O, D– RBCs were released and
transfused upon admission without pretransfusion
testing. Antibody screening performed, after release of
the units, showed a 1+ reaction with two cells of a
three-cell screening panel, using the ID-MTS gel test
(Ortho-Clinical Diagnostics, Raritan, NJ). Antibody
panel results showed reactivity with N+ cells in saline
room temperature and AHG tests using PEG. All other
clinically significant antibodies were excluded. The
autocontrol was positive in the same phases of testing
as the panel cells. The DAT was 4+ with polyspecific
AHG, 2+ with anti-IgG, and 3+ with anti-C3d. ABO/Rh
typing was initially discrepant between forward and
reverse typing, and the Rh control was positive.
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Fig. 1. Progression of patient’s LDH, bilirubin, and Hb levels by day of
hospitalization. Steroid therapy was initiated at the time of
presentation to the hospital. The patient was transfused with two
emergency-released uncrossmatched units of RBCs on Day 0 and
one unit of crossmatched RBCs on Day 1. (Arrows indicate RBC
transfusion.)
A 1-hour chloroquine diphosphate (Gamma-Quin,
Gamma Biologicals, Inc., Houston,TX) treatment of the
RBCs resolved the ABO typing and Rh control problem,
and the patient’s RBCs typed as group A, D+. The
antibody was interpreted as a warm autoantibody with
anti-N specificity.EDTA glycine-acid (EGA) treatment of
the RBCs (Gamma EGA kit, Gamma Biologicals, Inc.)
reduced the IgG reactivity from 2+ to w+, and the
patient’s EGA-treated RBCs typed 2+ for the N antigen.
An AHG crossmatch of the two group O, D–
emergency-released RBC units showed that one of the
units was incompatible with the patient’s serum.
Further testing determined that the incompatible unit
was N+; the other unit was N– and compatible. The
patient received one additional unit of N–, AHG-
crossmatch–compatible RBCs. Corticosteroid therapy
was administered and the patient’s Hb increased to
12.9 g/dL (Fig. 1).
Eight days after admission, a DAT of the patient’s
RBCs did not react with polyspecific AHG. The patient
was discharged on corticosteroids with laboratory
values of Hb = 13.2 g/dL, Hct = 36.7%, WBC = 9.2 ×
109/L, LDH = 1773 U/L, and total bilirubin = 1.4 mg/dL.
Follow-up transfusion testing two months later showed
a negative antibody screen, negative DAT, and no
ABO/Rh typing discrepancy.
Conclusion
After corticosteroid therapy, the autoimmune
hemolytic anemia resolved and the auto anti-N
disappeared. The etiology of the autoimmune hemo-
lytic anemia was assumed to be related to the acute
illness which was suspected to be of viral origin. There
have been at least three other case reports of auto anti-
N hemolytic anemia published (Table 1).1–3 Two of the
three reports were of pediatric patients (< 18 years
old) and, as in our patient, all had antibody resolution
after steroid therapy.1,2
Although infrequent, there have been at least 11
additional cases of naturally occurring auto anti-N in
four healthy individuals and seven patients, all without
evidence of clinical hemolysis or an associated
etiology.4–8 In addition, hemodialysis-associated anti-
N–like antibodies have been described when formalde-
hyde was used to sterilize dialysis equipment. These
antibodies were able to be adsorbed onto and eluted
from NN RBCs as well as from formaldehyde-treated
RBCs regardless of MN phenotype.9–12
Auto anti-N is infrequently encountered. In most
reported cases, the antibody did not cause clinical
hemolysis. In those few cases associated with hemo-
lysis,as in the present case, the hemolysis resolved with
steroid therapy.
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Table 1. Features of the cases of hemolytic anemia caused by auto anti-N
Case Initial Hb LDH Bilirubin Underlying
Study no. Age Sex Race (g/dL) (U/L) (mg/dL) diagnosis Steroids Transfusion Discharge Hb
Bowman et al.1 1 18 M UNK* 6.9 2200 3.1 Infectious Yes Yes (2 units) 10.2 (24 days)
mononucleosis
Dube et al.2 2 7 M UNK* 6.0 UNK* 1.7 UNK* Yes Yes (1 unit) 10 (10 days)
Cohen et al.3 3 21 F Caucasian 5.5 540 1.7 SLE† Yes No 12.8 (hospital stay
unreported)
This report 4 6 F Caucasian 2.7 7856 12.3 Questionable Yes Yes (3 units) 13.2 (4 days)
viral origin
* Unknown
† Systemic lupus erythematosus
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